-
Join 357 other subscribers
Blogroll
HIV/AIDS networks
Links
- bilaterals.org
- Fix the Patent Laws!
- FTA Malaysia
- HAI Europe
- Health Action International (HAI)
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS
- MSF Access Campaign
- Patent Opposition Database
- Public Citizen
- Stop EU-India FTA
- Stop Peru FTA
- Third World Network
- Treatment Action Group
- UAEM Europe
- UAEM evidence collection
- Universities Allied for Essential Medicines (UAEM)
Archives
-
Recent Posts
- Clamour against United Kingdom’s free-trade negotiator
- India, EU conclude another round of talks for proposed trade agreement
- Next round of India, UK talks for free trade agreement to be held in March
- ‘Playing with the lives of HIV patients’: Drug shortages force many to change medication regime
- Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know
Categories
Category Archives: Drugs
Clamour against United Kingdom’s free-trade negotiator
Groups from India and nearly 40 countries express concern about a leaked chapter from the proposed FTA that they say appears to represent ‘a wish list’ of the pharmaceutical industry. Source: The Telegraph, New Delhi, 20 Mar 2023 Over 200 … Continue reading
Posted in Access to Medecines, Drug prices, Drugs, FTA, Generics, Transparency, UK- INDIA Free Trade Agreement
Tagged AstraZeneca, Big Pharma, FTA, Generics, India, Intellectual property, UK
Leave a comment
Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know
Coronavirus disease (COVID-19) treatment pill Paxlovid (REUTERS) The WHO recommended Paxlovid over remdesivir, as well as over Merck’s molnupiravir pill and monoclonal antibodies. Source: Mint The World Health Organization(WHO) said that it “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid for patients … Continue reading
Posted in Access to Medicins, COVID-19, Drugs, Generics, Vaccines
Tagged COVID19, Generics, therapeutics, Vaccines
Leave a comment
Cutting Edge: After Covid, can genome sequencing help identify gene responsible for drug-resistant TB?
Tuberculosis is the leading infectious disease killer in the world and was only recently overtaken by Covid-19. Scientists are keen on exploring whole genome sequencing (WGS) for TB investigation. Source: Indian Express In the past two years, genome sequencing enabled … Continue reading
Posted in COVID-19, Diseases/Therapies, Drugs, Generics, Tuberculosis (TB)
Tagged COVID19, Generics
Leave a comment
The Covid treatment pill is here – and big pharma will ultimately decide who gets it
Experts are predicting demand for life-saving antiviral drugs will rapidly outpace supply. Like the vaccine, the poorest countries will be left until last Source: The Guardian Covid-19 has quietly become the gift that keeps on giving for big pharma. The … Continue reading
Posted in Access to Medecines, Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, Vaccines
Tagged COVID19, India, Medicine, Medicines
Leave a comment
Cipla to launch oral anti-viral covid drug Molnupiravir in India
Source:Mint Cipla Limited on Tuesday announced that the drug maker has been granted Emergency Use Authorisation (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in the country. Cipla plans to launch Molnupiravir under the brand … Continue reading
Shortage of key TB drug stress patients; activists urge govt to issue compulsory license
Source: TimeOfIndia MUMBAI: Stockouts are being reported across the country of a key patented drug, Delaminid, used in drug-resistant tuberculosis (DR-TB), hampering the government’s goal of TB elimination and causing hardship to patients. Much worse, the procurement of the drug … Continue reading
Posted in Access to Medecines, Access to Medicins, Diseases/Therapies, Generics, Tuberculosis (TB)
Tagged COVID19, Generics, India, Medicine, Medicines, therapeutics
Leave a comment
India’s antimicrobial resistance and how to solve this problem
Powerful medications are slowly becoming ineffective for many Indians due to misuse of antibiotics Source: FreePressJournal A recent ICMR report has left healthcare providers, patients, and infection control experts worried about the rising Antimicrobial Resistance in India. The report says … Continue reading
Posted in Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, India, Quality, Vaccines
Tagged COVID19, Generics, India, Medicine, Medicines, therapeutics
Leave a comment
AMR mitigation must top pharma industry’s agenda
To deal with this threat, the pharma sector must adopt environmentally sustainable production and supply chain measures. Source: TheHinduBusinessLine The economic and social consequences of the Covid-19 pandemic have reiterated the destructive capacity of untreatable infectious diseases. While we actively … Continue reading
Posted in Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, Right to Health, Vaccines
Tagged COVID19, Generics, Health, India, therapeutics, Vaccines
Leave a comment
Antimicrobial resistance is rising in India, says ICMR report.
Source: TheTimes Of India MUMBAI: More than 50% of the ICU patients battling a type of the Pneumonia caused by bacteria Klebsiella Pneumoniae will not respond to powerful antibiotics called carbapenem. Another antibiotics, imipenem, will not affect a mutated form of … Continue reading
Posted in Access to Medecines, Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, India, Vaccines
Tagged COVID19, Generics, India, Medicine, therapeutics
Leave a comment
Merck and Singapore sign deal on COVID-19 antiviral pill
Source: Reuters SINGAPORE, Oct 6 (Reuters) – Pharmaceutical company Merck announced on Wednesday a supply and purchase agreement with Singapore that will ensure it access to its experimental oral COVID-19 antiviral drug, the latest Asian country aiming to get supplies. … Continue reading
Posted in Access to Medecines, Access to Medicins, COVID-19, Diseases/Therapies, Generics, India
Tagged COVID19, Generics, India, Medicine, therapeutics
Leave a comment